RxDoctor Payments Data

Jack Peterson, DO

Family Medicine · Cochranton, PANPI 1790717163

Payments from drug & device makers

$2,971in general payments, 2019–2025

Across 196 payments — averaging $15.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$954
  • Amgen$589
  • GSK$227
  • Lilly USA, LLC$218
  • AbbVie$180
  • AstraZeneca$157
  • plus $646 from 10 others

What the payments were for

  • Food & beverage$2,94799%
  • Education$231%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,971 in reported general payments places this provider in the 80th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$56,767
Medicare patients
140
Services billed
557

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide49$53,769
OzempicSemaglutide26$28,969
JardianceEmpagliflozin24$24,996
RybelsusSemaglutide23$20,301
EliquisApixaban31$19,767
XareltoRivaroxaban25$17,845
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$12,068
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$7,273
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$4,908
SynthroidLevothyroxine Sodium56$4,475
Metoprolol Succinate179$3,226
Celecoxib21$2,212
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$1,760
Atorvastatin Calcium204$1,696
Pravastatin Sodium99$1,427

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$218$53,76949 claims
Novo NordiskOzempic, Rybelsus$954$49,27049 claims
Boehringer IngelheimJardiance$130$24,99624 claims
PfizerEliquis$132$19,76731 claims
Johnson & JohnsonXarelto$25$17,84525 claims
GSKTrelegy Ellipta, Anoro Ellipta$227$16,97630 claims
AstraZenecaBreztri Aerosphere$157$7,27312 claims
AbbVieSynthroid$180$4,47556 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Cochranton

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →